<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The precise relationship between GCF2 expression and <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> has not yet been established </plain></SENT>
<SENT sid="1" pm="."><plain>To clarify the metastatic potential of GCF2 in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, HT-29 cells stably suppressing GCF2 expression were injected into the spleens of severe combined immunodeficient (<z:mp ids='MP_0002536'>SCID</z:mp>) mice </plain></SENT>
<SENT sid="2" pm="."><plain>GCF2 suppression reduced the number of metastatic foci in the liver and reduced fibronectin-induced cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e>, migration, and invasion </plain></SENT>
<SENT sid="3" pm="."><plain>Downstream from the integrin signaling pathways, GCF2 regulates RhoA interaction with the RGS domain of <z:hpo ids='HP_0001909'>Leukemia</z:hpo> associated RhoGEF (LARG) </plain></SENT>
<SENT sid="4" pm="."><plain>Altogether, our results suggest that GCF2 plays an important role in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> by regulating RhoA-induced cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e>, migration, and invasion </plain></SENT>
</text></document>